Cargando…
Regional trends in the use of steroids and favipiravir for COVID-19 treatment
BACKGROUND: Infectious diseases are treated based on clinical guidelines, which usually require a large amount of data and time to formulate. Therefore, various treatments are tried and used in the early stages of epidemics of emerging and reemerging infectious diseases. In this study, we focused on...
Autores principales: | Asai, Yusuke, Tsuzuki, Shinya, Matsunaga, Nobuaki, Ohmagari, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791789/ https://www.ncbi.nlm.nih.gov/pubmed/36603374 http://dx.doi.org/10.1016/j.jiph.2022.12.014 |
Ejemplares similares
-
1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19
por: Asai, Yusuke, et al.
Publicado: (2022) -
Impact of regional heterogeneity on the severity of COVID-19
por: Tsuzuki, Shinya, et al.
Publicado: (2022) -
Temporal trends in microbial detection during the COVID-19 pandemic: Analysis of the Japan surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database
por: Endo, Akira, et al.
Publicado: (2023) -
Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2022) -
Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2022)